NCT04036695 is a NA clinical trial of Reveal LINQ insertable cardiac monitoring system in Arrythmia, Cardiac, sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's.

What drugs are being tested in NCT04036695?

Interventions in NCT04036695: Reveal LINQ insertable cardiac monitoring system.

What condition does NCT04036695 study?

NCT04036695 studies Arrythmia, Cardiac, Sudden Cardiac Death, Hemodialysis.

Is NCT04036695 still recruiting?

NCT04036695 is currently active, enrolled. Last updated 12 February 2025.

Last reviewed 2025-02-12 · How we verify

NCT04036695

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Arrhythmia in Hemodialysis Patients

Active, enrolled NA Last updated 12 February 2025

What this trial tests

NA trial testing Reveal LINQ insertable cardiac monitoring system in Arrythmia, Cardiac in 18 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

17 October 2019

Primary endpoint
1 May 2023

30 December 2025

Quick facts

Lead sponsor	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	18
Start date	17 October 2019
Primary completion	1 May 2023
Estimated completion	30 December 2025
Sites	2 locations across Canada

Drugs / interventions tested

Reveal LINQ insertable cardiac monitoring system

Conditions studied

Arrythmia, Cardiac — all drugs for Arrythmia, Cardiac →
Sudden Cardiac Death — all drugs for Sudden Cardiac Death →
Hemodialysis — all drugs for Hemodialysis →

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Who can join

18 and older, any sex, with Arrythmia, Cardiac or Sudden Cardiac Death. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients receiving dialysis for kidney failure suffer from very high rates of sudden cardiac death due to abnormal heart rhythms and perfusion defects associated with HD treatment. It has previously been recognized that patients suffer heart injury during the dialysis procedure which may be an important factor for investigation. The study uses a simple implantable device that can monitor heart rhythms over time to gather information on the type of abnormal rhythms that occur in dialysis patients. This information will be combined with ultrasound and x-ray scans of the heart that will also be collected. The goal is to understand the relationship between the abnormal rhythms and injury to the heart during dialysis and what causes these injuries. The information gathered in this study will be used to compare the accuracy of an in house personalized computational model to predict potential cardiac injuries when patients undergo HD treatment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Coronary Artery Disease and Intradialytic Myocardial Ischemia in Hemodialysis: An Exploratory Study Using Intradialytic Imaging.
Hur L, Islam A, Penny JD, Dorie J, et al · · 2025 · PMID 41342048 · DOI 10.1016/j.xkme.2025.101126

Verify or expand the search:

Other London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's trials

Trials by the same sponsor.

NCT07588711 — Transcutaneous Auricular Vagus Nerve Stimulation as a Treatment for Neuropathic Pain Following Spinal Cord Injury · NA · not yet recruiting
NCT07585292 — Transcutaneous Auricular Vagus Nerve Stimulation as a Treatment for Musculoskeletal Pain in Cerebral Palsy · NA · not yet recruiting
NCT07510906 — Evaluation of a Prostate-Targeted PET Imaging System (P-PET) for Detecting Prostate Cancer · NA · not yet recruiting
NCT03166072 — Health Education vs Meditation in Irreversible Age-Related Vision Loss Patients and Their Caregivers · NA · not yet recruiting
NCT06035809 — Sensory Motor Arousal Regulation Treatment (SMART) Study · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04036695 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Last refreshed: 12 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04036695.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing